In his first Mental Elf blog, Tim van der Es discusses a Biological Psychiatry paper on the genetic relationship between ADHD ...
Treatment-resistant depression complicates care, defying standard treatments, but new therapies are on the horizon, offering hope for more effective treatment options.
One in 20 U.S. adults experience seasonal depression, most often in winter. UVA professor Kim Penberthy shares self-care tips ...
In collaboration with Massachusetts General Hospital as its contract research organization, Alzamend aims to explore the unique properties of AL001 and its effects on lithium delivery in the brain ...
The following is a summary of “Spaced Transcranial Direct Current Stimulation for Major Depression,” published in the January ...
Objective This study aimed to investigate the incidence of overweight in patients with major depressive disorder (MDD) ...
CAPLYTA net product sales grew to $199.2 million, representing a 51%increase over the same period in 2023Full year 2024 ...
The following is a summary of “Comparative effectiveness of short-term psychodynamic psychotherapy and cognitive behavioral ...
Major depressive disorder (MDD) is a leading cause of disability worldwide, with a significant proportion of patients (10-20%) progressing to treatment-resistant depression (TRD).
Schizophrenia and major depressive disorder (MDD) may be genetically associated with increased risk for constipation but only the latter association appears to be clinically significant, according to ...
The Royal Devon University Healthcare NHS Foundation Trust is leading ground-breaking clinical research that has the potential to transform treatments for neuropsychiatric disorders.
Researchers recently discovered that eight different psychiatric conditions share a common genetic basis. A new study has now honed in on some of those shared genetic variants to understand their ...